CHEK1 and cancer: In the case of condylomatous lymphoma and diffuse large B‐cell lymphoma cancer cells, the CHK1 inhibitor AZD6738 and the Wee1 inhibitor AZD1775 delay S‐phase and accumulate DNA damage, and the synergistic impact of cytotoxicity is extremely apparent.417